Global Cardiac Marker Analyzer Market and Forecast, Impact of COVID-19, Product Analysis, Companies Business & Marketing Strategy, Major Deals

The global cardiac marker analyzer market is projected to reach US$ 1,120 Million by 2028. Cardiac marker analyzer provides high-quality point-of-care testing solutions used to diagnose heart diseases such as myocardial infarction and other cardiac-related diseases. These devices measure the levels of enzymes and proteins released from the heart in cardiac conditions like myocardial infarction, atrial fibrillation, and others. Cardiac marker analyzers are important for the prevention of the misdiagnosis of cardiac conditions. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 20.5 million lives each year. The increasing number of hospital admissions and critical care unit admissions due to CVDs creates a demand for the availability of cardiac marker analyzers for better disease diagnosis. The factors such as the increasing incidences of cardiovascular diseases, a rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as the issues related to regulatory and reimbursement processes and the high cost of the instruments are likely to hamper the growth of this market.

Recent Developments

• In April 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
• In September 2022, SRL Diagnostics, one of the chains of diagnostic laboratories in India, launched 'Heart Assure,' a specialized high-sensitivity Troponin I (hsTnI) test that can predict the risk of a cardiac event in the target population.
• Siemens Healthineers launched the third phase of its Strategy 2025 with the beginning of fiscal year 2022.

By Geography: Global Cardiac Marker Analyzer Market & Forecast - Key Takeaways

• North America dominated the global cardiac marker analyzer market.
• The United States dominates the cardiac marker analyzer market, due to increasing demand for point-of-care testing devices, rising focus on providing immediate diagnostic and treatment services to cardiac patients, and new product launches by major players.
• Europe contributed second highest share to the global cardiac marker analyzer market in 2022, driven by the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and growing awareness about the benefits of early diagnosis.
• Germany dominated the European cardiac marker analyzer market by country.
• In the UK, there are around 7.6 million people living with a heart or circulatory disease.
• Asia Pacific cardiac marker analyzer market is expected to grow at the fastest pace over the forecast period owing to rising affordability for advanced cardiac tests, modernization in the countries, and increasing disposable income. The rising prevalence and incidence of cardiovascular diseases in the region, especially in China and India, is expected to drive the demand for cardiac marker analyzers over the forecast period.

The report titled “Global Cardiac Marker Analyzer Market, By Region and Country, Product Analysis, Key Company’s Business & Marketing Strategy, Major Deals, Recent Developments - Forecast to 2028” provides a comprehensive assessment of the cardiac marker analyzer market.

This 146 Page report with 18 Figures and 31 Tables has been studied from 10 View Points:

1. Global - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
2. Global - Cardiac Marker Analyzer Market Share & Forecast (2015 - 2028)
3. By Region - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
4. By Country - Cardiac Marker Analyzer Market & Forecast (2015 - 2028)
5. Cardiac Marker Companies - Comparative Tests Analysis and Business & Marketing Strategy
6. Cardiac Marker Analyzer - Competitive Product Analysis
7. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis
8. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements
9. Emerging Markers Analysis
10. Recent Developments

By Geography - Cardiac Marker Analyzer Market & Forecast

1. North America

• United States
• Canada

2. Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

3. Asia Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of APAC

4. Latin America

• Brazil
• Mexico
• Rest of Latin America

5. Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Rest of Middle East & Africa

The Cardiac Marker Analyzers Covered in the report are as follows:

1. Triage MeterPro Analyzer
2. The i-STAT System
3. Cobas h 232 POC System
4. Access 2 Immunoassay System
5. Stratus CS Analyzer
6. RAMP 200
7. RAMP Reader
8. i-chroma DUO Analyzer
9. DXpress Reader Analyzer
10. PATHFAST Analyzer
11. QL Care Analyzer
12. Meritas POC Analyzer

Cardiac Marker Analyzer - Key Company Analysis

1. Alere (Now Abbott)
2. Abbott Point of Care
3. Quidel Corporation
4. Roche
5. Beckman Coulter
6. Siemens Healthineers
7. Response Biomedical
8. Boditech Med Inc.
9. Lifesign
10. LSI Medience Corporation
11. CardioGenics Holdings Inc.
12. Trinity Biotech

Data Sources

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and in-house analysis by the publisher's dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.